Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis ; volume:23 ; number:1 ; day:19 ; month:5 ; year:2021 ; pages:1-7 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (19.5.2021), 1-7, 12.2021
- Urheber
-
de Boysson, Hubert
Le Besnerais, Maelle
Blaison, Félix
Daumas, Aurélie
Jarrot, Pierre-André
Perrin, François
Tieulié, Nathalie
Maria, Alexandre
Duffau, Pierre
Gombert, Bruno
Samson, Maxime
Espitia, Olivier
Lambert, Marc
Mékinian, Arsène
Aouba, Achille
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02529-4
- URN
-
urn:nbn:de:101:1-2021091806531988693943
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- de Boysson, Hubert
- Le Besnerais, Maelle
- Blaison, Félix
- Daumas, Aurélie
- Jarrot, Pierre-André
- Perrin, François
- Tieulié, Nathalie
- Maria, Alexandre
- Duffau, Pierre
- Gombert, Bruno
- Samson, Maxime
- Espitia, Olivier
- Lambert, Marc
- Mékinian, Arsène
- Aouba, Achille
- SpringerLink (Online service)
Ähnliche Objekte (12)
Vision loss in patients with giant cell arteritis treated with tocilizumab
Tocilizumab for relapsing and remitting giant cell arteritis: a case series
Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
PET/CT uncovers cranial giant cell arteritis
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
The Diagnosis and Treatment of Giant Cell Arteritis
Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report
Integrated safety in tocilizumab clinical trials
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Vision loss in patients with giant cell arteritis treated with tocilizumab
Tocilizumab for relapsing and remitting giant cell arteritis: a case series
Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
PET/CT uncovers cranial giant cell arteritis
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
The Diagnosis and Treatment of Giant Cell Arteritis
Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report
Integrated safety in tocilizumab clinical trials
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Vision loss in patients with giant cell arteritis treated with tocilizumab
Tocilizumab for relapsing and remitting giant cell arteritis: a case series
Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
PET/CT uncovers cranial giant cell arteritis
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
The Diagnosis and Treatment of Giant Cell Arteritis
Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report
Integrated safety in tocilizumab clinical trials